New features correction of the dyslipidemia in patients with diabetes mellitus and metabolic cardiovascular risk factors
The prospects of using new drug of statine class – pitavastatine – in the prophylaxis and treatment of cardiovascular diseases have been considered in this review. The data of international іnvestigations on the comparative effi cacy of pitavastatine have been given; its pleiotropic effects, high...
Saved in:
Main Authors: | V. V. Syvolap, M. P. Gerasko |
---|---|
Format: | Article |
Language: | English |
Published: |
Zaporizhzhia State Medical and Pharmaceutical University
2014-04-01
|
Series: | Aktualʹnì Pitannâ Farmacevtičnoï ì Medičnoï Nauki ta Praktiki |
Subjects: | |
Online Access: | http://pharmed.zsmu.edu.ua/article/view/24831/22316 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Indicators of carbohydrate metabolism in a patient with dyslipidemia and impaired fasting glycemia receiving pitavastatin: a case report
by: A. A. Nekrasov, et al.
Published: (2023-01-01) -
Pitavastatin – a new inhibitor of the HMG-CoA reductase: peculiarities of clinical pharmacology and perspectives of its usage in treatment of cardiovascular diseases.
by: G. V. Dzyak, et al.
Published: (2013-12-01) -
REPRIEVE final results: What does it mean for guidelines in low‐ and middle‐income countries?
by: Simiso Sokhela, et al.
Published: (2025-06-01) -
Interdisciplinary Expert Consensus: the place of original pitavastatin in primary and secondary prevention of cardiovascular diseases
by: M. G. Bubnova, et al.
Published: (2024-12-01) -
Ersonified diagnostic and correction dyslipidemia approach by profiling of apolipoproteins
by: M. A. Kachkovsky, et al.
Published: (2020-12-01)